Skip to main content
Log in

Brief report: Plasma Β-endorphin and cortisol levels in autistic patients

  • Brief Reports
  • Published:
Journal of Autism and Developmental Disorders Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Campbell, M-, Adams, P., Small, A. M., Tesch, L. M., & Currens, E. L. (1988). Naltrexone in infantile autism.Psychopharmacology Bulletin, 24, 135–139.

    Google Scholar 

  • Campbell, M., Anderson, L. T., Small, A. M., Locasio, J., Lynch, N. S., & Choroco, M. C. (1990). Naltrexone in autistic children: a double-blind and placebo controlled study.Psychopharmacology Bulletin, 26.

  • Campbell, M. C., Overall, J. E., Small, A. M., Sokol, M. S., Spencer, E. K., Adams, P., Foltz, R. L., Monti, K. M., Perry, R., Nobler, M., & Roberts, E. (1989). Naltrexone in autistic children: An acute open dose range tolerance trial.Journal of Clinical Psychophnrmacology, 9, 448–449.

    Google Scholar 

  • Davidson, S., Til-Ad, I., Rogovin, H., Laron, Z., & Reisner, S. H. (1987). Cardiorespiratory depression and plasma b-endorphin levels in low-birth-weight infants during the first day of life.American Journal of Diseases of Children, 141, 145–148.

    Google Scholar 

  • Gilberg, C., Terenius, L., & Lonnerholm, G. (1985). Endorphin activity in childhood psychosis.Archives of General Psychiatry, 42, 780.

    Google Scholar 

  • Herman, B. H., Hammock, M. K., Arthur-Smith, A., Egan, J., Chatoor, L., Werner, A., & Zelnik, N. (1987). Naltrexone decreases self-injurious behavior.Annals of Neurology, 22, 550–552.

    Google Scholar 

  • Hoshino, Y., Yokoyama, F., Watanabe, M., Murata, S., Kaneko, M., & Kumashiro, H. (1987). The diurnal variation and response to dexamethasone suppression test of saliva cortisol level in autistic children.Japanese Journal of Psychiatry and Neurology, 41, 227–235.

    Google Scholar 

  • Jensen, J. B., Realmuto, G. M., & Garfinkel, B. D., (1985). The dexamethasone suppression test in infantile autism.Journal of the American Academy of Child Psychiatry, 24, 263–265.

    Google Scholar 

  • Panksepp, J. (1979). A neurochemical theory of autism.Trends in Neurosciences, 2, 174–177.

    Google Scholar 

  • Panksepp, J., Conner, R., Forister, P. K., Bishop, P., & Scott, J. P. (1983). Opioid effects on social behavior of kennel dogs.Applied Animal Etiology, 10, 63–74.

    Google Scholar 

  • Richardson, J. S., & Zaleski, W. A. (1983). Naloxone and self-mutilation.Biological Psychiatry, 18, 99–101.

    Google Scholar 

  • Sahley, T. L., & Panksepp, J. (1987). Brain opioids and autism: An updated analysis of possible linkages.Journal of Autism and Developmental Disorders, 17, 201–216.

    Google Scholar 

  • Sandman, C. A., Barron, J. L., & Colman, H. (1990a). An orally administered opiate blocker, naltrexone, attenuates self-injurious behavior.American Journal of Mental Retardation, 95, 93–102.

    Google Scholar 

  • Sandman, C. A., Barron, J. L., Chicz-DeMet, A., & DeMet, E. (1990b). Plasma b-endorphin and cortisol levels in autistic patients.American Journal of Mental Retardation, 95, 84–92.

    Google Scholar 

  • Sandman, C. A., Datta, P., Barron, J. L., Hoehler, F., Williams, C., & Swanson, J. (1983). Naloxone attenuates self-abusive behavior in developmentally disabled clients.Applied Research in Mental Retardation, 4, 5–11.

    Google Scholar 

  • Sandman, C. A., & Yessaian, N. (1986). Persisting subsensitivity of the striatal dopamine system after fetal exposure to b-endorphin.Life Sciences, 39, 1755–1763.

    Google Scholar 

  • Weizman, R., Weizman, A., Tyano, S., Szekely, B. A., & Sarne, Y. H. (1984). Humoral-endorphin blood levels in autistic, schizophrenic and healthy subjects.Psychopharmacology, 82, 368–370.

    Google Scholar 

  • Zadina, J. E., Kastin, A. J., Manasco, P. K., Pignatiello, M. F., & Nastiuk, K. L. (1987). Long-term hyperalgesia induced by neonatal b-endorphin and morphiceptin is blocked by neonatal Tyr-MIF-1.Brain Research, 409, 10–18.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

The support of Francis M. Crinella, Director, SDRI, is appreciated. The assistance of Lou Sarrao, Hugh Köhler, Carol Bitcon, Nadia Atie, Pal Donnelly, and the staff of Program V is sincerely appreciated. Supported in part by grant MH41446 NIMH.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sandman, C.A., Barron, J.L., Chicz-DeMet, A. et al. Brief report: Plasma Β-endorphin and cortisol levels in autistic patients. J Autism Dev Disord 21, 83–87 (1991). https://doi.org/10.1007/BF02207000

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02207000

Keywords

Navigation